Physicians Choice systemic chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Capecitabine, Carboplatin, Cisplatin, Eribulin, Gemcitabine, Nab-paclitaxel, Olaparib, Paclitaxel

Filter by location:

Birmingham, Alabama1 trial

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

University of Alabama at Birmingham

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.